Methods of treating diabetes using PDE 11A inhibitors

Details for Australian Patent Application No. 2003220342 (hide)

Owner Bayer Pharmaceuticals Corporation

Inventors Vasavada, Haren

Agent Davies Collison Cave

Pub. Number AU-B-2003220342

PCT Number PCT/US03/08132

PCT Pub. Number WO2003/077949

Priority 60/389,036 13.06.02 US; 60/364,697 14.03.02 US

Filing date 14 March 2003

Wipo publication date 29 September 2003

Acceptance publication date 7 June 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/00 (2006.01)

A61K 31/133 (2006.01) - having hydroxy groups, e.g. sphingosine

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/195 (2006.01)

A61K 31/198 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/522 (2006.01)

A61K 31/64 (2006.01) - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

A61K 31/7034 (2006.01)

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/06 (2006.01) Drugs for disorders of the endocrine system

A61P 5/38 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 Drugs for disorders of the respiratory system

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/389,036 13.06.02 US; 60/364,697 14.03.02 US

6 November 2003 Application Open to Public Inspection

  Published as AU-B-2003220342

7 June 2007 Application Accepted

  Published as AU-B-2003220342

4 October 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003220343-COMPOSITIONS OF PENTAFLUOROPROPANE

2003220341-VIRTUAL TEST MARKET SYSTEM AND METHOD